PT Indofarma Tbk Class B Statistics
PT Indofarma Tbk Class B (INAF) Stock Statistics & Valuation Metrics
Total Valuation
PT Indofarma Tbk Class B has a market cap or net worth of $390.51B. The enterprise value is $1.12T.
- Market Cap
- $390.51B
- Enterprise Value
- $1.12T
Share Statistics
PT Indofarma Tbk Class B has 3,099,267,600 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 3,099,267,600
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
PT Indofarma Tbk Class B’s return on equity (ROE) is 0.11 and return on invested capital (ROIC) is -140.11%.
- Return on Equity (ROE)
- 0.11
- Return on Assets (ROA)
- -0.15
- Return on Invested Capital (ROIC)
- -140.11%
- Return on Capital Employed (ROCE)
- 2.15
- Revenue Per Employee
- 192.32M
- Profits Per Employee
- -98.97M
- Employee Count
- 788
- Asset Turnover
- 0.28
- Inventory Turnover
- 2.02
Valuation Ratios
The current PE Ratio of PT Indofarma Tbk Class B is -6.46. PT Indofarma Tbk Class B’s PEG ratio is -0.06.
- PE Ratio
- -6.46
- PS Ratio
- 2.32
- PB Ratio
- -0.55
- Price to FCF
- -13.44
- Price to Operating Cash Flow
- -13.44
- PEG Ratio
- -0.06
Income Statement
In the last 12 months, PT Indofarma Tbk Class B had revenue of 151.55B and earned -77.99B in profits. Earnings per share was -25.16.
- Revenue
- 151.55B
- Gross Profit
- -19.53B
- Operating Income
- -208.22B
- Pretax Income
- -71.46B
- Net Income
- -77.99B
- EBITDA
- -195.04B
- Earnings Per Share (EPS)
- -25.16
Cash Flow
In the last 12 months, operating cash flow was -47.77B and capital expenditures -1, giving a free cash flow of -47.77B billion.
- Operating Cash Flow
- -47.77B
- Free Cash Flow
- -47.77B
- Free Cash Flow per Share
- -9.38
Dividends & Yields
PT Indofarma Tbk Class B pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -7.44%
- Earnings Yield
- -15.48%
Important Dates
PT Indofarma Tbk Class B upcoming earnings date is Apr 21, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Oct 30, 2026
- Next Earnings Date
- Apr 21, 2027
- Ex-Dividend Date
- ―
Financial Position
PT Indofarma Tbk Class B as a current ratio of 0.19, with Debt / Equity ratio of -99.06%
- Current Ratio
- 0.19
- Quick Ratio
- 0.05
- Debt to Market Cap
- 1.79
- Net Debt to EBITDA
- -3.56
- Interest Coverage Ratio
- -6.84
Taxes
In the past 12 months, PT Indofarma Tbk Class B has paid 6.53B in taxes.
- Income Tax
- 6.53B
- Effective Tax Rate
- -0.09
Enterprise Valuation
PT Indofarma Tbk Class B EV to EBITDA ratio is -6.23, with an EV/FCF ratio of -37.27.
- EV to Sales
- 6.44
- EV to EBITDA
- -6.23
- EV to Free Cash Flow
- -37.27
- EV to Operating Cash Flow
- -37.27
Balance Sheet
PT Indofarma Tbk Class B has $5.69B in cash and marketable securities with $700.28B in debt, giving a net cash position of -$694.60B billion.
- Cash & Marketable Securities
- $5.69B
- Total Debt
- $700.28B
- Net Cash
- -$694.60B
- Net Cash Per Share
- -$224.12
- Tangible Book Value Per Share
- -$228.68
Margins
Gross margin is -5.45%, with operating margin of -111.19%, and net profit margin of -35.96%.
- Gross Margin
- -5.45%
- Operating Margin
- -111.19%
- Pretax Margin
- -31.89%
- Net Profit Margin
- -35.96%
- EBITDA Margin
- -103.43%
- EBIT Margin
- -111.19%
Analyst Forecast
The average price target for PT Indofarma Tbk Class B is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -26.37%
- EPS Growth Forecast
- ―
